Stocklytics Platform
Asset logo for symbol GMED
Globus Medical
Asset logo for symbol GMED



Income Statement (GMED)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
gross Profit$335.50M$351.04M$248.24M$215.14M$205.86M
NET Income-$7.11M$15.03M$998.00K$57.71M$49.12M
total Revenue$606.66M$616.53M$383.63M$291.61M$276.68M

Balance Sheet (GMED)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
cash Equivalents-----
net Debt$172.23M$53.11M$243.41M-$306.45M-$217.68M
stockholders Equity$3.92B$3.99B$4.18B$1.98B$1.91B
total Assets$4.94B$5.08B$5.35B$2.21B$2.14B
total Debt$526.29M$520.40M$523.03M--
total Liabilities$1.02B$1.08B$1.16B$227.40M$234.80M

Cash Flow (GMED)

itemMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
financing Cash Flow-$115.72M-$237.27M$1.42M$1.08M$2.94M
free Cash Flow$23.81M$81.79M$28.95M$17.16M$37.32M
investing Cash Flow---$80.86M$52.22M$10.99M
operating Cash Flow$52.38M$104.67M$50.48M$35.02M$53.31M

Globus Medical (GMED) Financials

Globus Medical Inc (GMED) is a medical device company that specializes in the design, development, and commercialization of musculoskeletal implants and related technologies. The company's products are used in the treatment of spinal disorders, trauma, and orthopedic surgeries. Globus Medical Inc (GMED) offers a wide range of products, including spinal fusion implants, spinal fixation devices, biologics, and surgical instruments. The company generates revenue through the sale of its products to hospitals, ambulatory surgery centers, and other healthcare providers. As of December 31, 2020, Globus Medical Inc (GMED) had total revenue of $824.3 million. Gross profit for the same period was $564.8 million. Net income from stockholders was $203.6 million. EBIT (earnings before interest and taxes) was $205.7 million, while EBITDA (earnings before interest, taxes, depreciation, and amortization) was $290.4 million.
The balance sheet of Globus Medical Inc (GMED) as of December 31, 2020, showed that the company had total assets of $2.07 billion. Total liabilities were $697.7 million, and stockholders' equity was $1.37 billion. Cash equivalents for the period were $173.3 million, and net debt was $18 million. The company's financial statements also indicate that it had positive operating cash flow of $293.8 million, investing cash flow of -$206.3 million, and financing cash flow of -$47.2 million. Free cash flow, a measure of a company's ability to generate cash after accounting for capital expenditures, was $87.5 million for the same period. These financials demonstrate the strong financial position of Globus Medical Inc (GMED) and its ability to generate revenue and cash flow from its operations.
add Globus Medical  to watchlist

Keep an eye on Globus Medical

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.


Sign up for our newsletter

Join our exclusive community of over one million investment enthusiasts and receive our free newsletter filled with analysis, news, and updates every weekday.

Take Your Investments to a Whole New Level